Evidence Hub

Electrochemical sensor modified with nickel-doped zinc oxide nanoparticles for sensitive monitoring of rizatriptan benzoate in human plasma

Elsayed MA, Saeed MA, Mahmoud AM, Mostafa NS

Analytical methods : advancing methods and applications, 2026

Abstract

Rizatriptan benzoate (RZB), a first-line therapy for the acute treatment of migraine, requires sensitive and reliable monitoring in pharmaceutical formulations and biological matrices to ensure effective quality control and therapeutic drug monitoring. In this work, a sustainable, novel and cost-effective electrochemical sensor was established for the sensitive determination of RZB by modifying a carbon paste electrode (CPE) with nickel-doped zinc oxide nanoparticles (Ni-ZnO NPs) via a simple precipitation procedure. The prepared nanoparticles were characterized using X-ray diffraction (XRD), scanning electron microscopy (SEM) coupled with energy-dispersive X-ray spectroscopy (EDX), and Fourier-transform infrared spectroscopy (FT-IR), confirming their crystalline nature. The Ni-ZnO/CPE demonstrated remarkable electrocatalytic efficiency for RZB oxidation in phosphate buffer solution at pH 6.0. Utilizing differential pulse voltammetry, the sensor showed linearity over the concentration interval of 0.04-20 µM. Moreover, the sensor showed excellent repeatability and intermediate precision, with relative standard deviation (RSD) values below 1.5%. The sensor was effectively employed for RZB detection in tablets and human plasma, exhibiting adequate recovery rates of 99.71-101.26% and 100.22-101.26%, respectively. The suggested approach revealed favorable analytical performance compared with previously reported DPV procedures, offering a lower limit of detection of 0.01 µM and…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free